Sign Up to like & get
recommendations!
0
Published in 2021 at "Communications Biology"
DOI: 10.1038/s42003-021-02522-2
Abstract: Transforming growth factor beta (TGFβ) and programmed death-ligand 1 (PD-L1) are often overproduced in refractory squamous cell carcinoma (SCC). We examined spatial patterns of PD-L1 + cells in mouse and human SCCs and found that…
read more here.
Keywords:
squamous cell;
tgf;
tgf blockade;
combined tgf ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Gastroenterology"
DOI: 10.1053/j.gastro.2023.05.038
Abstract: BACKGROUND AND AIMS TGFβ plays pleiotropic roles in pancreatic cancer including promoting metastasis, attenuating CD8 T cell activation, and enhancing myofibroblast differentiation and deposition of extracellular matrix. However, single-agent TGFβ inhibition has shown limited efficacy…
read more here.
Keywords:
cell;
pancreatic cancer;
tgf blockade;
chemotherapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2069877
Abstract: Abstract The antitumor immune response induced by chemotherapy has attracted considerable attention. However, the immunosuppressive tumor microenvironment hinders the immune activation effect of cancer chemotherapy. TGF-β plays a key role in driving tumor immunosuppression and…
read more here.
Keywords:
antitumor;
tgf blockade;
dual responsive;
tumor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-18-0558
Abstract: Radiotherapy can be synergistically combined with immunotherapy in mouse models, extending its efficacious effects outside of the irradiated field (abscopal effects). We previously reported that a regimen encompassing local radiotherapy in combination with anti-CD137 plus…
read more here.
Keywords:
tgf blockade;
combination;
efficacy;
anti cd137 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-18-0850
Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains remarkably lethal with a 5-year survival rate of 8%. This is mainly attributed to the late stage of presentation, as well as widespread resistance to conventional therapy. In addition, PDAC…
read more here.
Keywords:
regression;
inhibition;
tgf;
promote ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood"
DOI: 10.1182/blood.2022017097
Abstract: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by clonal expansion of myeloid cells, notably megakaryocytes (MKs), and aberrant cytokine production leading to bone marrow (BM) fibrosis and insufficiency. Current treatment options are limited. TGF-b1,…
read more here.
Keywords:
cell;
tgf blockade;
garp;
garp tgf ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Immunotherapy"
DOI: 10.2217/imt-2022-0079
Abstract: Aims: A comprehensive meta-analysis was conducted to explore the efficacy of TGF-β blockade therapies in solid tumors. Patients & methods: Results of overall survival (OS), progression-free survival (PFS), time to progression (TTP) and overall response rate…
read more here.
Keywords:
tgf blockade;
tgf;
meta analysis;
solid tumors ... See more keywords